Reframing the E-cigarette Debate To Address Genuine Harm Reduction
|
|
- Prosper Harrell
- 5 years ago
- Views:
Transcription
1 Reframing the E-cigarette Debate To Address Genuine Harm Reduction Michael J. Thun, M.D., M.S. National Tobacco Control Conference Washington DC December 2, 2014
2 Debates over regulation of E-cigarettes and other ENDS often framed as the Purists vs. the Pragmatists
3 False Construct - Those who favor regulation are labeled Purists (i.e. fanatics who consider any form of nicotine addiction to be evil ). - Those who dispute the need for regulation characterize themselves as Pragmatists (i.e. those who accept the inevitability of nicotine addiction and contend that e-cigarettes will displace more harmful combustible products).
4 The pragmatists contend that whatever toxicity e-cigarettes have cannot possibly be as bad as conventional cigarettes.
5 But The real issue is how to develop prudent & effective public health policy in the context of important unknowns
6 What Are the Most Important Unresolved Questions? 1. Are e-cigarettes better than existing cessation therapies to help smokers quit? 2. What are the long-term health problems from using ENDS? 3. Are e-cigarettes a gateway to (or a replacement for) cigarette smoking among non-smoking youth?
7 I will discuss briefly: - The criteria for true Harm Reduction - The disconnect between the stated goal of harm reduction and the current marketing of e-cigarettes. - A recent example of harm reduction gone terribly awry
8 Part I Criteria for Harm Reduction The product must: - Reduce risks for individual smokers & - Reduce harms from tobacco use in the overall population
9 Do E-Cigarettes Reduce the Risks for Individual Smokers? Only if: - E-cigarettes are more effective than established cessation therapies in helping smokers quit. & - Smokers quit entirely or use e-cigarettes exclusively.
10 Otherwise - Smokers who continue to smoke but also use E-cigarettes (dual use) will increase their individual risk if this delays cessation. - Dual use ( For when you can t smoke ) was once the industry rationale for marketing e-cigarettes.
11 How Might E-cigarettes Adversely Affect Health at the Population Level? If they: - Increase uptake among adolescents who would not otherwise use tobacco. - Renormalize cigarette smoking - Have unanticipated health effects - Provide a gateway to smoking combustible tobacco products
12 Part 2 The disconnect between the goal of Harm Reduction and the current marketing of e-cigarettes
13 Much of the advertising and promotion of e-cigarettes is aimed at the youth market, not smokers
14 E-cigarette Flavors
15
16 E-cigarette Flavors
17
18
19
20
21
22
23 ports Illustrated Swimsuit Edition
24
25 Cautionary Tale of Harm Reduction Gone Terribly Awry
26 Tar (mg) Nicotine (mg) Decrease in Average Machine-Measured Tar and Nicotine in US Cigarettes s Cellulose acetate filters 1959 More porous cigarette paper Late 1960s Expanded tobacco TAR 1970s Air ventilation holes NICOTINE Values before 1968 are estimated from available data D. Hoffman personal communication Year Source: Modified from NCI Smoking and Tobacco Control Monograph 1997, p
27 Smoking Machines - Developed by tobacco industry in 1930s. - Adopted by FTC in 1967/1968.
28 Many studies conducted since the 1960s reportedly showed lower lung cancer risk with lower tar yield.
29 Epidemiologic studies of Low yield, cigarettes & lung cancer and lung cancer, Bross 1969 Hammond 1977 (M) Hammond 1977 (W) Hawthorne 1978 Todd 1978 Wynder 1979 (M) Wynder 1979 (W) Rimington 1981 Lee 1981 (M) Lee 1981 (W) Vutuc 1982 (W) Borland 1983 Vutuc 1983 (M) Lubin 1984 (M) Lubin 1984 (W) Benhamou 1985 Alderson 1985 (M) Alderson 1985 (W) Pettiti 1985 Buffer 1986 Pathak 1986 Benhamou
30 American Cancer Society Public Relations Ad
31 What epidemiologists weren t aware of: Barclay Grooved Filter We seem to have found a cigarette that shows low deliveries on machine smoking and much higher deliveries when people smoke it memo from filter inventor RR Johnson to Brown & Williamson executives - not recorded in Johnson s official laboratory notebook. Source: Kozlowski et al Tob Control 2005;14:64-70.
32 Tar (mg) Nicotine (mg) Epidemiologists largely unaware of the distinction between ventilated & unventilated filter tip cigarettes s Cellulose acetate filters 1959 More porous cigarette paper Late 1960s Expanded tobacco TAR 1970s Air ventilation holes NICOTINE Values before 1968 are estimated from available data D. Hoffman personal communication Year Source: Modified from NCI Smoking and Tobacco Control Monograph 1997, p
33 Smoking machines do not accurately simulate humans smoking modern cigarettes Smoking machine protocol * Actual yield to smoker * Puff volume 35 ml ml Puff frequency Amount of cigarette smoked Every 60 sec. Stops at specified length sec. Every 30 All Machines also do not capture deeper inhalation, length of retention, and greater surface area of lung tissue being exposed. * Hammond D et al, Lancet 2006
34 We expected lung cancer risk to decrease over this period in smokers. 34
35 Contrary to expectation Our analyses found that lung cancer risks in smokers increased from CPS-I to CPS-II in men & women. 35
36 Rate per 100,000 Age-specific lung cancer mortality increases among women who smoke across all three time periods Contemporary CPS-II CPS-I Attained Age 36
37 Rate per 100,000 Age-specific lung cancer death rates continue to increase in male smokers until the 1980s Current Smokers Contemporary CPS-II CPS-I Attained Age 37
38 Conclusions - True Harm reduction is defined by the outcome, not by enthusiasm for the concept. - Current promotion of e-cigarettes is aimed at maximizing sales, not at harm reduction. - There are major uncertainties about the ultimate effect of e-cigarettes on both individual and population risk. - What is certain is that unregulated marketing is detrimental. 38
39 What Would He Do? 39
40 Thank You
Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013
Peter G. Shields, MD Tobacco Products Scientific Advisory Committee (TPSAC) August 16, 2013 Conceptual Framework for Evaluating MRTPs: Objectives Provide a framework for evaluating all tobacco products
More informationCigarettes cause cancer. Tobacco contains nicotine. Nicotine is an addictive drug.
Q: Does nicotine cause cancer? Cigarettes cause cancer. Tobacco contains nicotine. Nicotine is an addictive drug. These facts make a lot of people nervous about nicotine. But it is NOT the nicotine in
More informationThere is no such thing as a safe cigarette, and no safe level of exposure to the carcinogens or other toxic substances contained in tobacco smoke.
POSITION STATEMENT Dangers of reduced-harm cigarettes Smokers considering changing to so-called reduced harm cigarettes should not conclude that these products are a less harmful alternative Key messages
More informationReduced Risk Review March Keith Lenghaus
Reduced Risk Review March 2005 Keith Lenghaus Reducing Exposure Add filters (1950s) Rapid gain in market share Reduce tar, nicotine (1960s on) FTC method Competitive advantage Advertising Pollay et al
More informationThe Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need
The Evidence on E-cigarettes: Evaluating What We Have and Identifying What We Need Ken Warner University of Michigan School of Public Health U.S. E-cigarette Summit, Washington, DC, May 8, 2017 Conflicts
More informationCase 1:99-cv GK Document Filed 01/10/14 Page 1 of 11. Exhibit D. Online newspaper exemplars
Case 1:99-cv-02496-GK Document 6021-4 Filed 01/10/14 Page 1 of 11 Exhibit D Online newspaper exemplars Case 1:99-cv-02496-GK Document 6021-4 Filed 01/10/14 Page 2 of 11 Philip Morris USA Corrective Statements
More informationCHANGE IN NICOTINE YIELDS
MASSACHUSETTS DEPARTMENT OF PUBLIC HEALTH CHANGE IN NICOTINE YIELDS 1998-2004 DATA SUBMITTED IN ACCORDANCE WITH MASSACHUSETTS GENERAL LAWS CHAPTER 94: Section 307B, 105 CMR 660.000 Report produced by:
More informationWayne Hall and Coral Gartner University of Queensland
Wayne Hall and Coral Gartner University of Queensland Current policy situation in Australia What is its rationale and how is it defended? An ethical analysis of Current Australian policy A graduated approach
More informationTHE IMPORTANCE OF POINT OF SALE
THE IMPORTANCE OF POINT OF SALE Counter Tobacco Allison E. Myers, MPH Kurt M. Ribisl, PhD Adapted from a presentation given January 16, 2013 Office of Smoking and Health Centers for Disease Control and
More informationELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE?
ELECTRONIC CIGARETTES WHAT S THE BOTTOM LINE? E-cigarettes have the potential to benefit adult smokers who are not pregnant if used as a complete substitute for regular cigarettes and other smoked tobacco
More informationIntroduction. Principles
NHS Health Scotland s position statement on Electronic Nicotine Delivery Systems ENDS - e-cigarettes and other smoking simulator products 31 October 2014 Introduction NHS Health Scotland is the national
More informationThe Latest on Vaping Among U.S. Teens
The Latest on Vaping Among U.S. Teens Jon Macy, PhD, MPH Indiana University School of Public Health Bloomington Presentation Outline Overview of Electronic Nicotine Delivery Systems (ENDS) New Prevalence
More informationAmerican Vaping Association
Vaping.info American Vaping Association Gregory Conley, J.D., M.BA. President American Vaping Association Research Fellow Heartland Institute Member -- Gregory Conley Consulting, LLC Twitter: @GregTHR
More informationThe Voice of Local Public Health in New York State. May 12, 2014
The Voice of Local Public Health in New York State May 12, 2014 Testimony before the Senate Standing Committee on Health To consider including electronic cigarettes in the existing Clean Indoor Air Act
More informationCigarette Packaging in Ireland: The Plain Future.
http://www.cit.ie Cigarette Packaging in Ireland: The Plain Future. Wesley Connolly Tong and Maurice Murphy New Laws in Ireland Ireland has become the first country in Europe and the second in the world
More informationNicotine Reduction Workshop Role of nicotine in smoking behaviour
Nicotine Reduction Workshop Role of nicotine in smoking behaviour Derek Mariner APSTW02 11 October 2016 2016 CORESTA Congress, Berlin, Germany, 9-13 October 2016 Introduction Nicotine itself is not especially
More informationREGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING. Ron Borland PhD
REGULATORY OPTIONS FOR MOVING TO THE ELIMINATION OF SMOKING Ron Borland PhD Tobacco Smoking Extremely harmful to health Kills over half of long-term users Reduces quality life years in most Slows recovery
More informationPolicy Options for the Regulation of Electronic Cigarettes
Policy Options for the Regulation of Electronic Cigarettes Consultation submission Your details This submission was completed by: (name) Philip Hope / Assoc Prof Chris Atkinson Address: (street/box number)
More informationRE: Docket No. FDA-2014-N , Electronic Cigarettes and the Public Health
VIA ELECTRONIC SUBMISSION June 30, 2015 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, Rm. 1061 Rockville, MD 20852 RE: Docket No. FDA-2014-N-1936-0001, Electronic
More informationPopulation impacts of snus tobacco initiation and cessation
Population impacts of snus tobacco initiation and cessation Karl Lund, Ph.d Research Director, Tobacco Polarcircle Norway Registered sales of tobacco products in Norway 1909-2014 World war II Cigarettes
More informationMenthol Cigarette Report
Menthol Cigarette Report Tobacco Products Scientific Advisory Committee Meeting July 15, 2010 Corinne G. Husten, MD, MPH Senior Medical Advisor Center for Tobacco Products, FDA 1 Menthol Cigarette Report
More informationHeat-not-Burn Products: Scientific Assessment of Risk Reduction
Heat-not-Burn Products: Scientific Assessment of Risk Reduction Tobacco Merchants Association 2015 Annual Meeting Moira Gilchrist PhD Philip Morris International R&D May 20th 2015 The Objective is Harm
More informationThe gateway theory. Pr Jean-François ETTER PhD (political science) E-cigarette Summit London, November 17, Competing interests: none
The gateway theory Pr Jean-François ETTER PhD (political science) E-cigarette Summit London, November 17, 2016 Competing interests: none Enormous political influence Since 1970s: used to support the idea
More informationRe: Docket No. FDA-2013-N-0521, Menthol in Cigarettes, Tobacco Products; Request for Comments
November 22, 2013 Division of Dockets Management (HFA-305) Food and Drug Administration 5630 Fishers Lane, rm. 1061 Rockville, MD 20852 Re: Docket No. FDA-2013-N-0521, Menthol in Cigarettes, Tobacco Products;
More informationRecent Findings from the ITC Project on the Effectiveness of Health Warnings in the Asia Pacific Region
Recent Findings from the ITC Project on the Effectiveness of Health Warnings in the Asia Pacific Region Geoffrey T. Fong, Ph.D. University of Waterloo and Ontario Institute for Cancer Research Tobacco
More informationRADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS
Ending the Tobacco Epidemic RADM Patrick O Carroll, MD, MPH Senior Advisor, Assistant Secretary for Health, US DHSS Tim McAfee, MD, MPH Senior Medical Officer, Office on Smoking and Health, CDC www.nwcphp.org/hot-topics
More informationUNITED STATES REGULATION OF TOBACCO PRODUCTS. Presented by Mitch Zeller Center Director FDA Center for Tobacco Products
UNITED STATES REGULATION OF TOBACCO PRODUCTS Presented by Mitch Zeller Center Director FDA Center for Tobacco Products May 24, 2016 OVERVIEW OF TODAY S PRESENTATION Highlights of the Deeming Final Rule
More informationSmoking Harm Reduction: If Not Now When?
Smoking Harm Reduction: If Not Now When? K. Michael Cummings, PhD, MPH Medical University of South Carolina The E-Cigarette Summit Washington DC, April 30, 2018 Outline for my talk Historical context,
More informationWho is Targeting You? The Tobacco Industry Those who want to profit from your smoking
Who is Targeting You? The Tobacco Industry Those who want to profit from your smoking The Tobacco Industry like no other Tobacco is the ONLY legal product sold that is lethal when used exactly as the manufacturer
More informationTobacco dependence as a chronic disease: Clinical and public health perspectives Tim Milbrandt, MS, CTTS
Tobacco dependence as a chronic disease: Clinical and public health perspectives Tim Milbrandt, MS, CTTS Learning objectives At the end of this presentation the participations will be able to Identify
More informationTobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products
Tobacco-related risk perceptions in the regulation of tobacco products at the FDA Center for Tobacco Products David B. Portnoy, PhD, MPH Conrad J. Choiniere, PhD Office of Science FDA, Center for Tobacco
More informationElectronic Nicotine Delivery System (ENDS) Surveillance in the United States
Electronic Nicotine Delivery System (ENDS) Surveillance in the United States Brian King, PhD, MPH Deputy Director for Research Translation (Acting) Office on Smoking and Health Centers for Disease Control
More informationSmoking Cessation: A readily modifiable risk factor
Robert L. Keith MD FCCP Associate Professor of Medicine Medical Director of Respiratory Therapy Eastern Colorado Health Care System University of Colorado Denver Smoking Cessation: A readily modifiable
More informationDefinition of Drug. an article (other than food) intended to affect the structure or any function of the body. Sections 201 (g)(1)(c)
Definition of Drug an article (other than food) intended to affect the structure or any function of the body Sections 201 (g)(1)(c) Increase Nicotine Content by Adding Nicotine to Filters, Wrappers, etc.
More informationFDLI Tobacco Products Regulation and Policy Conference Joe Murillo Vice President, Regulatory Affairs October 27, 2017
FDLI Tobacco Products Regulation and Policy Conference Joe Murillo Vice President, Regulatory Affairs October 27, 2017 Altria Client Services Vice President, Regulatory Affairs FDLI Presentation Oct. 27,
More informationE-Cigarettes: Current Perspective
E-Cigarettes: Current Perspective Aruni Bhatnagar, Ph.D. Professor of Medicine University of Louisville Louisville, KY Electronic Cigarettes E-cigarettes are electronic nicotine delivery systems (ENDS),
More informationUPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY
UPDATE ON PREMARKET TOBACCO PRODUCT AUTHORIZATION PATHWAY Presented by Ii-Lun Chen, M.D Director Division of Individual Health Science Office of Science, CTP, FDA Disclaimer: This is not a formal dissemination
More informationNeurobiology of Tobacco Dependence
Neurobiology of Tobacco Dependence Jennifer Bluem Moran, MA, TTS Nicotine Dependence Center Mayo Clinic http://ndc.mayo.edu 2013 MFMER slide-1 Cigarettes and Tobacco Dependence Cigarette smoke complex
More informationMARKETING STANDARDS FOR MEMBERSHIP
MARKETING STANDARDS FOR MEMBERSHIP The Vapor Technology Association (VTA) is a leading national trade association in the electronic cigarette and vapor product industry. VTA represents the manufacturers,
More informationElectronic Nicotine Delivery Systems: Patterns of Use and Disparities
Electronic Nicotine Delivery Systems: Patterns of Use and Disparities Daniel P. Giovenco, PhD, MPH Assistant Professor of Sociomedical Sciences Columbia University Mailman School of Public Health Outline
More informationTobacco & Mississippi Youth
Tobacco & Mississippi Youth Youth Tobacco Use Where we are now: 1998-2012 - Early current tobacco use decreases have leveled off in recent years - Why? Education & community activities Taxes & policies
More informationRaze-On. Tobacco 101
Raze-On Tobacco 101 Key Messages Most people don t use tobacco Tobacco kills Nicotine is addictive The tobacco industry targets youth Tobacco Use in Teens 80% of adult smokers start before the age of 18
More informationMichael Russell s take on nicotine, smoking and harm reduction: how well does it stand up, 25 years on?
Michael Russell s take on nicotine, smoking and harm reduction: how well does it stand up, 25 years on? Martin Jarvis Department of Behavioural Science & Health University College London martin.jarvis@ucl.ac.uk
More informationSACTob Position Statement on Nicotine and Its Regulation in Tobacco and Non-Tobacco Products.
SACTob Position Statement on Nicotine and Its Regulation in Tobacco and Non-Tobacco Products. Background Over the past two decades a wealth of research findings have pointed to nicotine as the key pharmacological
More informationPredicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance
Predicting the population health effects of changing tobacco exposures: Statistical models for regulatory compliance NASEM ENDS Workshop February 2017 Annette M. Bachand, Ph.D. Goal of Statistical Models:
More informationPolicy Options for the Regulation of Electronic Cigarettes
Policy Options for the Regulation of Electronic Cigarettes Consultation submission Your details This submission was completed by: Address: (name) Mark Forsyth (street/box number) 3 Queens Wharf (town/city)
More informationHow to Regulate E-Cigarettes? Are we asking the right questions?
How to Regulate E-Cigarettes? Are we asking the right questions? Eric N. Lindblom Director, Tobacco Control and Food & Drug Law O Neill Institute for National & Global Health Law Georgetown University
More informationNICOTINE AND TAR IN CIGARETTE TOBACCO: A LITERATURE REVIEW TO INFORM POLICY DEVELOPMENT. A report for the Ministry of Health.
NICOTINE AND TAR IN CIGARETTE TOBACCO: A LITERATURE REVIEW TO INFORM POLICY DEVELOPMENT A report for the Ministry of Health January 1998 Final Report Tony Blakely Epidemiology Group Project Leader Michael
More informationUse all articles listed
You're a doctor, and a new patient comes into your office. She admits to being a smoker. It's your job to inform her of the health hazards related to smoking. Describe below the health hazards related
More informationHOPE OR HAZARD? What Research Tells Us About Potentially Reduced-Exposure Tobacco Products
HOPE OR HAZARD? What Research Tells Us About Potentially Reduced-Exposure Tobacco Products Hope or Hazard? What Research Tells Us About Potentially Reduced-Exposure Tobacco Products. TABLE TABLE OF OF
More informationIntroduction, Summary, and Conclusions
Chapter 1 Introduction, Summary, and Conclusions David M. Burns, Lawrence Garfinkel, and Jonathan M. Samet Cigarette smoking is the largest preventable cause of death and disability in developed countries
More informationPackaging and Labeling of Tobacco Products in Hong Kong Vienna LAI Wai-yin Executive Director Hong Kong Council on Smoking and Health
Packaging and Labeling of Tobacco Products in Hong Kong Vienna LAI Wai-yin Executive Director Hong Kong Council on Smoking and Health August 20, 2013 MPOWER M Monitor Tobacco Use & Prevention Policies
More informationHealth behavior science and global public health:
Health behavior science and global public health: Transnational research collaborations to address noncommunicable diseases James F. Thrasher, MA, MS, PhD February 24, 2016 INSTITUTO NACIONAL DE SALUD
More informationPublic Health England s Independent Expert E-Cigarettes Evidence Review
Public Health England s Independent Expert E-Cigarettes Evidence Review Misinformation, Misreporting and Public Understanding Ann McNeill Contents 1. PHE e-cigarette evidence updates 2. Public understanding
More informationTobacco Addiction. Addiction Terminology. Jack E. Henningfield, PhD Johns Hopkins School of Medicine Pinney Associates
Tobacco Addiction Jack E. Henningfield, PhD Johns Hopkins School of Medicine Pinney Associates Addiction Terminology Addiction: common term applied to maladaptive drug-seeking behavior Equivalent to American
More informationTowards a Smokefree Generation: A Tobacco Control Plan for England. Tim Baxter, Department of Health, England
Towards a Smokefree Generation: A Tobacco Control Plan for England 1 Tim Baxter, Department of Health, England Smoking rates are falling fast... 25 Adult Smoking prevalence in England (daily and non daily)
More informationKevin Walton, Ph.D. Chief, Clinical Research Grants Branch Division of Therapeutics and Medical Consequences NIDA. No disclosures
Kevin Walton, Ph.D. Chief, Clinical Research Grants Branch Division of Therapeutics and Medical Consequences NIDA No disclosures NIDA Organizational Chart Office of Diversity & Health Disparities Office
More informationTobacco Surveillance in the United States
Tobacco Surveillance in the United States Gary Giovino Roswell Park Cancer Institute National Conference on Tobacco OR Health San Francisco, California November 20, 2002 Outline of Presentation Public
More informationElectronic Cigarettes, Nicotine and Policy Implications
Electronic Cigarettes, Nicotine and Policy Implications Neal L Benowitz MD University of California San Francisco The E-Cigarette Summit The Royal Society London November 17, 2016 Disclosures Dr Benowitz
More informationCMA Submission: Submission to the Senate Standing Committee on Social Affairs, Science and Technology
CMA Submission: CMA s Recommendations for Bill S-5: An Act to amend the Tobacco Act and the Non-smokers Health Act and to make consequential amendments to other Acts Submission to the Senate Standing Committee
More informationLung Cancer Epidemiology & Prevention. A/Prof Fraser Brims
Lung Cancer Epidemiology & Prevention A/Prof Fraser Brims Introduction Lung cancer burden Global, Australia, WA Current smoking rates Other risks and associations Prevention Tobacco control E-cigarettes
More informationE-CIGARETTES: THREAT OR OPPORTUNITY? Anna B Gilmore (1) Greg Hartwell (2)
E-CIGARETTES: THREAT OR OPPORTUNITY? Anna B Gilmore (1) Greg Hartwell (2) (1) Corresponding author: Anna B Gilmore, Department of Health and UK Centre for Tobacco and Alcohol Studies (UKCTAS) University
More informationHHS Public Access Author manuscript J Patient Cent Res Rev. Author manuscript; available in PMC 2016 February 04.
In adult smokers unwilling or unable to quit, does changing from tobacco cigarettes to electronic cigarettes decrease the incidence of negative health effects associated with smoking tobacco? A Clin-IQ
More informationA combination of licensed medication and professional support is four times more likely to achieve a stop in smoking behaviour.
PHA Position Statement E-cigarettes 30 May 2014 The Public Health Agency (PHA) considers E-cigarettes with caution at this time. E-cigarettes are not licensed nicotine replacement products. They are not
More informationResearch Study: Court-Ordered Corrections of Tobacco Industry Racketeering PRELIMINARY REPORT Background Methods Results Conclusions
Research Study: Court-Ordered Corrections of Tobacco Industry Racketeering National Poll Shows Support for Policies, Lawmakers Rejection of Tobacco Industry Influences PRELIMINARY REPORT Background Internal
More informationTMA Annual Conference, Williamsburg, May 20-22, Public Health. The Swedish Experience
TMA Annual Conference, Williamsburg, May 20-22, 2012 Effects of Snus Use on Public Health The Swedish Experience Lars M. Ramström PhD Director, Institute for Tobacco Studies Stockholm, Sweden Email: lars.ramstrom@tobaccostudies.com
More informationWelcome Superheros! YOUR. Winter Awareness Workshop 2017 BE A HERO IN COMMUNITY!
Welcome Superheros! BE A HERO IN YOUR COMMUNITY! Winter Awareness Workshop 2017 WHAT ARE E-CIGARETTES /VAPING DEVICES? Devices that allow users to inhale aerosol containing nicotine or other substances.
More informationNicotine Reduction: Harm Reduction not Prohibition
Nicotine Reduction: Harm Reduction not Prohibition Eric C. Donny, Ph.D. Endowed Professor, Departments of Physiology & Pharmacology and Social Sciences & Health Policy Director, Center for the Evaluation
More informationThe Effect of Puff Profile and Volume on the Yields of E-Cigarettes
The Effect of Puff Profile and Volume on the Yields of E-Cigarettes Dr M J Taylor, Filtrona Technology Centre Smoke Science/Product Technology Meeting Seville, Spain, 29 September to 03 October 2013 Introduction
More informationPerceived Effectiveness of Pictorial versus Textual Health Warning Labels on Waterpipe Tobacco Packages (Tumbac packages)
Perceived Effectiveness of Pictorial versus Textual Health Warning Labels on Waterpipe Tobacco Packages (Tumbac packages) NELLY LAYOUN, PhD, MPH Epidemiologist Misperceived as less harmful than cigarette
More informationSelected Agent Characteristics. Product type Nicotine dose levels Constituents (e.g., tar, CO) and ingredients (e.g., additives) Market share
Tobacco Measurement Stephen Marcus, Ph.D. Tobacco Control Research Branch, Behavioral Research Program, Division of Cancer Control and Population Sciences Public Health Model Agent -- tobacco products
More informationAssessment of the Tobacco Heating System (THS) 2.2, A Candidate Modified Risk Tobacco Product: From Concept to Early Clinical Data
Assessment of the Tobacco Heating System (THS) 2.2, A Candidate Modified Risk Tobacco Product: From Concept to Early Clinical Data Global Forum on Nicotine 2015 Bruce D. Clark PhD Philip Morris International
More informationMenthol cigarettes are a public health problem
Menthol cigarettes are a public health problem ANDREA VILLANTI, PHD MPH JUNE 22, 2016 disclosures Andrea Director The Adjunct Department Johns Villanti, PhD, MPH, CHES for Regulatory Science and Policy
More informationPresented by: The Association of State and Territorial Health Officials (ASTHO) January 29 th, :00-3:30pm ET
Presented by: The Association of State and Territorial Health Officials (ASTHO) January 29 th, 2015 2:00-3:30pm ET For Audio Component Play audio through your computer speakers Audience participants should
More informationTobacco Packages: Ads for tobacco companies or tools for public health?
Tobacco Packages: Ads for tobacco companies or tools for public health? Heather Selin Tobacco Control Advisor, PAHO/WHO 2005 The Importance of the Package To tobacco companies: Critical link between ads
More informationCOMMENT PREPARED AFTER THE TPSAC MEETIING ON CAMEL SNUS. significantly reduce harm to individuals or benefit population health.
COMMENT PREPARED AFTER THE TPSAC MEETIING ON CAMEL SNUS RJR failed to demonstrate that Camel Snus, as actually used by consumers, will significantly reduce harm to individuals or benefit population health.
More informationJackson Tobacco Reduction Coalition 1715 Lansing Avenue, Jackson, MI Phone (517) FAX (517)
Jackson Tobacco Reduction Coalition 1715 Lansing Avenue, Jackson, MI 49202 Phone (517) 768-2131 FAX (517) 788-4373 Date: August 16, 2018 Contact: Rhonda Rudolph, Coordinator, Jackson Tobacco Reduction
More informationFDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality
FDA s Action Agenda to Reduce Tobacco Related-Cancer Incidence and Mortality Lawrence Deyton, M.S.P.H., M.D. Director, FDA Center for Tobacco Products June 11, 2012 FDA s Vision To make tobaccorelated
More informationE-cigarettes vs. Conventional Cigarettes and their Health Effects on the Environment. Elizabeth Do 5/01/15 GCH 360
E-cigarettes vs. Conventional Cigarettes and their Health Effects on the Environment Elizabeth Do 5/01/15 GCH 360 Introduction The rate of smoking has been declining in the United States, but the new discovery
More informationCOMPREHENSIVE TOBACCO-FREE SCHOOL POLICY
TOBACCO AND TOBACCO PRODUCTS COMPREHENSIVE TOBACCO-FREE SCHOOL POLICY 1. INTENT All students shall possess the knowledge and skills necessary to avoid all tobacco use, and school leaders shall actively
More informationShould FDA try to move smokers to e-cigarettes or other less harmful tobacco-nicotine products and, if so, how?
Should FDA try to move smokers to e-cigarettes or other less harmful tobacco-nicotine products and, if so, how? Jeff Weiss General Counsel/EVP of Gov. Affairs of NJOY, LLC FDLI - October 20, 2017 FDA s
More informationTexas Bill to Regulate Vapor Products. Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes
Texas Bill to Regulate Vapor Products Over the past few years, electronic cigarettes, also commonly referred to as e-cigarettes or vapor, have been trending all over the state of Texas as a tobacco alternative,
More informationComponents of a Successful Policy
Components of a Successful Policy 1. Include the rationale for developing and implementing the policy Include the reasons for having a policy: health effects of tobacco (first-hand and secondhand smoke),
More informationDissolvable Tobacco Products
Dissolvable Tobacco Products James E. Dillard Senior Vice President, Regulatory Affairs Altria Client Services 1 l Altria Client Services (on behalf of PM USA and USSTC) I Presentation to the Tobacco Products
More informationTobacco Cessation, E- Cigarettes and Hookahs
Objectives Tobacco Cessation, E- Cigarettes and Hookahs Discuss evidence-based tobacco cessation interventions including pharmacologic options. Review e-cigarette and hookah facts and safety considerations.
More informationSmoking, e-cigs and reduced risk products. Dr John Schoonbee, IMS November 2017
Smoking, e-cigs and reduced risk products Dr John Schoonbee, IMS November 2017 2 The storyline smoking is bad yet many folks still smoke because quitting is very hard is it better, if one cannot quit,
More informationThe Tobacco and Vaping Products Act: Implications for E-Cigarette Point-of-Sale Promotion
The Tobacco and Vaping Products Act: Implications for E-Cigarette Point-of-Sale Promotion Background: E-Cigarette Point-of-Sale Promotion September 2018 Key Message: Vaping e-cigarettes can lead to dependence,
More informationTobacco Surveillance in the United States
Tobacco Surveillance in the United States Gary Giovino Roswell Park Cancer Institute National Conference on Tobacco OR Health Boston, Massachusetts December 10, 2003 Outline of Presentation Public health
More informationAnti-Smoking Advertising and Youth Smoking
Anti-Smoking Advertising and Youth Smoking Melanie Wakefield PhD VicHealth Senior Research Fellow and Deputy Director Centre for Behavioural Research in Cancer Anti-Cancer Council of Victoria First National
More informationProblem Which option Additional option Additional comments definition Yes No change No further observations.
Department of Health, United Kingdom electronic contribution rec. 317 - by Mr Lee McGill lee.mcgill@dh.gsi.gov.uk Question 1 - scope Problem Which option Recommend option Additional comments Yes No change
More informationDuelling letters: which one would you sign?
POST-PRINT This is a post-print (post-refereed, final accepted) version of the manuscript that has been published in Tobacco Control. The citation details and the link to the final publisher version are
More information2 nd European Harm Reduction Conference session. Tobacco and Harm Reduction. Prof. Jacques Cornuz, Policlinique Médicale Universitaire, Lausanne
2 nd European Harm Reduction Conference session Tobacco and Harm Reduction Prof. Jacques Cornuz, Policlinique Médicale Universitaire, Lausanne Background The majority of smokers want to stop -once in the
More informationTOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES
TOBACCO PLAYBOOK DÉJÀ VU: E-CIGARETTES LAURA DE LA RAMBELJE AND PATRICIA HEILER, MICHIGAN DEPARTMENT OF COMMUNITY HEALTH MICHIGAN CANCER CONSORTIUM, NOVEMBER 5, 2014 These slides are the property of the
More informationElectronic Cigarettes: What They Are, How They re Marketed, & How We Can Protect Our Youth
Electronic Cigarettes: What They Are, How They re Marketed, & How We Can Protect Our Youth Amy Barkley Coalition for a Tobacco- Free West Virginia Charleston, WV February 26, 2014 Big Picture Points Tobacco
More informationNeurobiology of Tobacco Dependence
Neurobiology of Tobacco Dependence Jeff Poterucha, MA, TTS Mayo Clinic Nicotine Dependence Center Rochester, MN 2013 MFMER slide-1 What we are up against! 2013 MFMER slide-2 Cigarettes and Tobacco Dependence
More informationconsistent with the industry documents we note in our September letter.
February 18, 2010 Division of Dockets Management (HFA-305) Food and Drug Administration Department of Health and Human Services 5630 Fishers Lane, Room 1061 Rockville, MD 20852 RE: Docket Number FDA-2010-N-0020
More informationModeling of E-cigarette Use. David Levy, PhD Georgetown University
Modeling of E-cigarette Use David Levy, PhD Georgetown University No Conflicts of Interest Funding has been received for this work from NIDA (NIH) under grant R01DA036497, NCI CISNET U01CA199284, and the
More informationTobacco Control Tūranga Update Focus on reducing nicotine content in tobacco to help smokers quit
Tobacco Control Tūranga Update Focus on reducing nicotine content in tobacco to help smokers quit Professor Chris Bullen and Dr Marewa Glover, Co-Directors, Tobacco Control Research Turanga 18 March 2015
More informationKent, OH May 22, 2018 TOBACCO 21
Kent, OH May 22, 2018 TOBACCO 21 Tobacco 21 Proposed Goals Raise the legal age for tobacco to 21 in Kent. Reduce tobacco use. Save lives and improve health. Nationwide Support is Growing 75% of adults
More information